Treatment of Proximal Deep-Vein Thrombosis With the Oral Direct Factor Xa Inhibitor Rivaroxaban (BAY 59-7939): The ODIXa-DVT (Oral Direct Factor Xa Inhibitor BAY 59-7939 in Patients With Acute Symptomatic Deep-Vein Thrombosis) Study
Circulation - United States
doi 10.1161/circulationaha.106.668020
Full Text
Open PDFAbstract
Available in full text
Date
July 10, 2007
Authors
Publisher
Ovid Technologies (Wolters Kluwer Health)